Atlas Trials

Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

Clinical trial NCT05895500 · COMPLETED

Trial details

NCT number
NCT05895500
Sponsor
Nvision Laser Eye Centers
Status
COMPLETED
Study type
OBSERVATIONAL
Dry EyeAsthenopia
Start date
2023-05-10
Primary completion
2023-11-09
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.